ACLY and hepatocellular carcinoma: In summary, the dysregulated expression of ACLY, ACSL3, ACSL4, FABP4, FABP5, SCD1, SLC27A5, and SREBP1 in HCC underscores their critical roles in lipid metabolism alterations contributing to tumour development and progression.